Published 23 days ago • loading... • Updated 22 days ago

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER

Summary by Inside Ottawa Valley

LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced new findings from the SLIM LIVER study (also known as A5371). These data suggest that blood-based epigenetic…

10 Articles

All

Left

Center

Right

The Record

+8 Reposted by 8 other sources

Lean Left

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER

23 days ago·Waterloo, Canada

Read Full Article

pipelinereview

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - Pipelinereview

IMC-M113V was well tolerated, with no dose-limiting toxicities Signals of dose-dependent reduction in active reservoir, and viral control after complete antiretroviral treatment interruption in some PLWH Enrollment in MAD portion of the trial continues with higher doses being evaluated OXFORDSHIRE, UK & CONSHOHOCKEN, PA & GAITHERSBURG, MD, USA I March 10, 2025 I Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial…

22 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year